rs797045741
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_001291867.2(NHS):βc.310_345delβ(p.Pro104_Ala115del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00128 in 1,054,192 control chromosomes in the GnomAD database, including 7 homozygotes. There are 393 hemizygotes in GnomAD. Variant has been reported in ClinVar as Benign (β β ).
Frequency
Genomes: π 0.0021 ( 1 hom., 66 hem., cov: 23)
Exomes π: 0.0012 ( 6 hom. 327 hem. )
Consequence
NHS
NM_001291867.2 inframe_deletion
NM_001291867.2 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.11
Genes affected
NHS (HGNC:7820): (NHS actin remodeling regulator) This gene encodes a protein containing four conserved nuclear localization signals. The encoded protein functions in eye, tooth, craniofacial and brain development, and it can regulate actin remodeling and cell morphology. Mutations in this gene have been shown to cause Nance-Horan syndrome, and also X-linked cataract-40. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant X-17376059-AGGCGGCGCCCGCAGCCGGCGAGGCGTCCTCGGCGGC-A is Benign according to our data. Variant chrX-17376059-AGGCGGCGCCCGCAGCCGGCGAGGCGTCCTCGGCGGC-A is described in ClinVar as [Benign]. Clinvar id is 211598.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-17376059-AGGCGGCGCCCGCAGCCGGCGAGGCGTCCTCGGCGGC-A is described in Lovd as [Benign].
BS2
High Hemizygotes in GnomAd4 at 66 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NHS | NM_001291867.2 | c.310_345del | p.Pro104_Ala115del | inframe_deletion | 1/9 | ENST00000676302.1 | NP_001278796.1 | |
NHS | NM_198270.4 | c.310_345del | p.Pro104_Ala115del | inframe_deletion | 1/8 | NP_938011.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NHS | ENST00000676302.1 | c.310_345del | p.Pro104_Ala115del | inframe_deletion | 1/9 | NM_001291867.2 | ENSP00000502262 | P4 | ||
NHS | ENST00000380060.7 | c.310_345del | p.Pro104_Ala115del | inframe_deletion | 1/8 | 1 | ENSP00000369400 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00213 AC: 236AN: 110635Hom.: 1 Cov.: 23 AF XY: 0.00195 AC XY: 65AN XY: 33323
GnomAD3 genomes
AF:
AC:
236
AN:
110635
Hom.:
Cov.:
23
AF XY:
AC XY:
65
AN XY:
33323
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00540 AC: 112AN: 20722Hom.: 3 AF XY: 0.00711 AC XY: 36AN XY: 5060
GnomAD3 exomes
AF:
AC:
112
AN:
20722
Hom.:
AF XY:
AC XY:
36
AN XY:
5060
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00117 AC: 1108AN: 943519Hom.: 6 AF XY: 0.00110 AC XY: 327AN XY: 298549
GnomAD4 exome
AF:
AC:
1108
AN:
943519
Hom.:
AF XY:
AC XY:
327
AN XY:
298549
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00214 AC: 237AN: 110673Hom.: 1 Cov.: 23 AF XY: 0.00198 AC XY: 66AN XY: 33373
GnomAD4 genome
AF:
AC:
237
AN:
110673
Hom.:
Cov.:
23
AF XY:
AC XY:
66
AN XY:
33373
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 17, 2017 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 21, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Nance-Horan syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at